The link between accurately measuring glucose levels and monitoring osmotic pressure was made in the 1970s after an incident at a regional hospital in Førde, Norway.
The son of Olav Ellingsen was admitted to the hospital with a severely swollen face and bulging eyeballs. The doctors confirmed that these symptoms came from the son’s teenage diabetes condition.
Improving life for diabetes patients
Today people with diabetes are dependent on painful and time-consuming glucose measurement processes based on old technologies. Sencell is a revolutionary device for people with diabetes, providing functions far beyond what present day products and technology does.
The Sencell sensor is invisible once it is injected under a person’s skin and lasts a minimum of six months without calibration required. The technology has a range of use cases and can be applied by medical professionals, people with diabetes and high-performance professionals such as professional athletes, firefighters, and soldiers.
Lifecare work with acknowledged research and development partners across Europe.
Lifecare has historically been organised as a virtual company through outsourcing of services for key functions. At the same time, we have had a strong focus on maintaining and further developing the undisputed ownership of our unique IP.
Public support schemes
Lifecare has received approval of public funding schemes from the Research Council of Norway and the EU.
Join our journey
A Norwegian life-science company solving one of the largest medical challenges we are facing.